PL394295A1 - Sposób oznaczania kalprotektyny, zestaw do stosowania w tym sposobie, zautomatyzowany aparat oraz sposób diagnozowania choroby - Google Patents

Sposób oznaczania kalprotektyny, zestaw do stosowania w tym sposobie, zautomatyzowany aparat oraz sposób diagnozowania choroby

Info

Publication number
PL394295A1
PL394295A1 PL394295A PL39429503A PL394295A1 PL 394295 A1 PL394295 A1 PL 394295A1 PL 394295 A PL394295 A PL 394295A PL 39429503 A PL39429503 A PL 39429503A PL 394295 A1 PL394295 A1 PL 394295A1
Authority
PL
Poland
Prior art keywords
calprotectin
determination
diagnosing
kit
disease
Prior art date
Application number
PL394295A
Other languages
English (en)
Inventor
Erling Sundrehagen
Original Assignee
Axis-Shield Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis-Shield Asa filed Critical Axis-Shield Asa
Publication of PL394295A1 publication Critical patent/PL394295A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Optical Head (AREA)
  • Gyroscopes (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL394295A 2002-12-20 2003-12-22 Sposób oznaczania kalprotektyny, zestaw do stosowania w tym sposobie, zautomatyzowany aparat oraz sposób diagnozowania choroby PL394295A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0229747.1A GB0229747D0 (en) 2002-12-20 2002-12-20 Assay

Publications (1)

Publication Number Publication Date
PL394295A1 true PL394295A1 (pl) 2011-09-12

Family

ID=9950111

Family Applications (2)

Application Number Title Priority Date Filing Date
PL377476A PL216385B1 (pl) 2002-12-20 2003-12-22 Sposób testowania do wykrywania możliwości wystąpienia lub skłonności do choroby niedokrwiennej serca lub udaru
PL394295A PL394295A1 (pl) 2002-12-20 2003-12-22 Sposób oznaczania kalprotektyny, zestaw do stosowania w tym sposobie, zautomatyzowany aparat oraz sposób diagnozowania choroby

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL377476A PL216385B1 (pl) 2002-12-20 2003-12-22 Sposób testowania do wykrywania możliwości wystąpienia lub skłonności do choroby niedokrwiennej serca lub udaru

Country Status (16)

Country Link
US (3) US10101325B2 (pl)
EP (2) EP1739430B1 (pl)
JP (2) JP4653492B2 (pl)
CN (3) CN101893635B (pl)
AT (2) ATE380345T1 (pl)
AU (1) AU2003295142A1 (pl)
CA (2) CA2504876A1 (pl)
DE (2) DE60317931T2 (pl)
DK (2) DK1573335T3 (pl)
ES (2) ES2323475T3 (pl)
GB (1) GB0229747D0 (pl)
NO (1) NO20052161L (pl)
PL (2) PL216385B1 (pl)
PT (1) PT1573335E (pl)
SI (1) SI1573335T1 (pl)
WO (1) WO2004057341A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
US7659087B2 (en) 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
SG150497A1 (en) 2004-07-23 2009-03-30 Aspenbio Pharma Inc Methods and devices for diagnosis of appendicitis
EP1862805A1 (en) * 2006-06-01 2007-12-05 University of Zürich The use of mrp 8/14 levels for discrimination of individuals at risk of acute coronary syndromes
WO2010101950A1 (en) * 2009-03-02 2010-09-10 Catholic Healthcare West Diagnostic devices and methods of use
US10183969B2 (en) * 2009-05-07 2019-01-22 Chreto Aps Method for purification of target polypeptides
US9574977B2 (en) * 2013-02-26 2017-02-21 Innova Prep Liquid to liquid biological particle concentrator with disposable fluid path
EP2511704A1 (en) 2011-04-13 2012-10-17 Immundiagnostik AG Assay method for intrinsic acute kidney injury
NO20110895A1 (no) * 2011-06-21 2012-12-24 Magne Fagerhol Kompetitive S100A9 immunoanalyser
ES2402457B2 (es) * 2011-10-19 2014-01-20 Universidade De Vigo Procedimiento para el diagnóstico de derrame pleural maligno mediante la determinación de la concentración de calprotectina en líquido pleural.
US9439334B2 (en) 2012-04-03 2016-09-06 X-Card Holdings, Llc Information carrying card comprising crosslinked polymer composition, and method of making the same
US9122968B2 (en) 2012-04-03 2015-09-01 X-Card Holdings, Llc Information carrying card comprising a cross-linked polymer composition, and method of making the same
CN107255721A (zh) * 2012-09-12 2017-10-17 博格有限责任公司 标志物用于识别心脏毒性剂的用途
US10906287B2 (en) 2013-03-15 2021-02-02 X-Card Holdings, Llc Methods of making a core layer for an information carrying card, and resulting products
WO2018146129A1 (en) * 2017-02-07 2018-08-16 Orthogenics As Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
EP3385712A1 (en) 2017-04-03 2018-10-10 Gentian AS Improved calprotectin assay
US11714082B2 (en) 2017-05-09 2023-08-01 Immundiagnostik Ag Method for determination of members of the S100 family of calcium binding proteins by immunoturbidimetry
CN108196066A (zh) * 2018-01-22 2018-06-22 安徽伊普诺康生物技术股份有限公司 一种测定钙防卫蛋白的试剂盒及其制备使用方法
US11361204B2 (en) 2018-03-07 2022-06-14 X-Card Holdings, Llc Metal card
KR20230009421A (ko) * 2020-05-13 2023-01-17 노르딕 바이오사이언스 에이/에스 칼프로텍틴 검정

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287202A (en) 1978-05-26 1981-09-01 Horrobin David F Treatment and/or prophylaxis of spasms of coronary arteries
JPS55162059A (en) * 1979-06-05 1980-12-17 Mochida Pharmaceut Co Ltd Measuring method for antigen, antibody or their complex and measurement reagent kit
US4401765A (en) * 1981-09-01 1983-08-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
US4480042A (en) * 1981-10-28 1984-10-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
GB8318754D0 (en) * 1983-07-11 1983-08-10 Fagerhol M K F Human proteins anti-sera test kits
JPS60139621A (ja) 1983-12-27 1985-07-24 Grelan Pharmaceut Co Ltd 抗血栓剤
JPS625970A (ja) 1985-03-15 1987-01-12 Terumo Corp ピラジン誘導体およびこれを含有する血小板凝集抑制剤
EP0310361A3 (en) * 1987-09-30 1989-05-24 Beckman Instruments, Inc. Tridentate conjugate and method of use thereof
GB2218100A (en) * 1988-03-02 1989-11-08 Erling Sundrehagen Conjugates for the detection and/or quantification of antigenic substances in body fluids
CA2023803C (en) * 1989-08-23 1999-05-18 Takeshi Miyazaki Method for measuring an immunologically active material and apparatus suitable for practicing said method
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
US5776348A (en) 1995-02-07 1998-07-07 Massachusetts Institute Of Technology Mineral precipitation system and method for inhibiting mineral precipitate formation
DK0937259T3 (da) 1996-11-01 2005-01-31 Magne K Fagerhol Fremgangsmåde til ekstraktion af proteiner
ATE530180T1 (de) 1997-04-02 2011-11-15 Brigham & Womens Hospital Verfahren zur ermittlung der individualen risikoprofile atherosklerotischen erkrankungen
GB9816088D0 (en) * 1998-07-23 1998-09-23 Axis Biochemicals Asa System
WO2000011479A1 (en) * 1998-08-20 2000-03-02 Axis-Shield Asa Assay method for cardiovascular disease
WO2001002853A2 (en) * 1999-07-05 2001-01-11 K.U. Leuven Research & Development DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY
JP2003508453A (ja) 1999-08-31 2003-03-04 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド アテローム性動脈硬化疾患の予防における診断的ツールとしての全身性炎症マーカー
FR2800636A1 (fr) * 1999-11-05 2001-05-11 Bio Merieux Particules composites, conjugues derives, leur procede de preparation et utilisations
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
US20030059461A1 (en) 2000-06-06 2003-03-27 Sibtech, Inc. Molecular delivery vehicle for delivery of selected compounds to targets
KR100778102B1 (ko) * 2000-08-29 2007-11-27 가부시키가이샤 티에프비 재현성이 양호한 응집면역측정법 및 시약
JP2002318233A (ja) * 2001-04-19 2002-10-31 Shino Test Corp 測定対象物質の比濁法測定試薬及び測定対象物質の比濁法測定方法
CA2414073A1 (en) * 2001-05-04 2002-11-14 Gunars E. Valkirs Diagnostic markers of acute coronary syndromes and methods of use thereof
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
FR2872579B1 (fr) * 2004-06-30 2006-11-24 Pasteur Institut Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha
US7623910B2 (en) * 2006-03-10 2009-11-24 University Of Rochester ECG-based differentiation of LQT1 and LQT2 mutation

Also Published As

Publication number Publication date
DK1739430T3 (da) 2009-07-13
EP1739430A2 (en) 2007-01-03
CN1729398B (zh) 2012-04-04
EP1739430A3 (en) 2007-01-17
PL377476A1 (pl) 2006-02-06
US20060134705A1 (en) 2006-06-22
JP5744385B2 (ja) 2015-07-08
JP2006510895A (ja) 2006-03-30
JP2010019849A (ja) 2010-01-28
AU2003295142A1 (en) 2004-07-14
US20190049439A1 (en) 2019-02-14
CN1729398A (zh) 2006-02-01
DE60317931D1 (en) 2008-01-17
EP1573335A2 (en) 2005-09-14
DE60327007D1 (de) 2009-05-14
ES2323475T3 (es) 2009-07-16
GB0229747D0 (en) 2003-01-29
CA2729365C (en) 2018-09-18
ATE380345T1 (de) 2007-12-15
CA2504876A1 (en) 2004-07-08
JP4653492B2 (ja) 2011-03-16
EP1739430B1 (en) 2009-04-01
PT1573335E (pt) 2007-12-21
ES2297250T3 (es) 2008-05-01
WO2004057341A3 (en) 2004-10-21
CN101893635A (zh) 2010-11-24
SI1573335T1 (sl) 2008-04-30
US20110318847A1 (en) 2011-12-29
NO20052161L (no) 2005-07-19
PL216385B1 (pl) 2014-03-31
NO20052161D0 (no) 2005-05-03
DE60317931T2 (de) 2008-11-13
CN102608326A (zh) 2012-07-25
WO2004057341A2 (en) 2004-07-08
ATE427498T1 (de) 2009-04-15
EP1573335B1 (en) 2007-12-05
DK1573335T3 (da) 2008-04-14
US10101325B2 (en) 2018-10-16
CA2729365A1 (en) 2004-07-08
CN101893635B (zh) 2014-04-09

Similar Documents

Publication Publication Date Title
NO20052161D0 (no) Analysemetode for hjerte-karsykdom
Sener et al. Rapid real-time detection of procalcitonin using a microcontact imprinted surface plasmon resonance biosensor
Ertürk et al. Microcontact imprinting based surface plasmon resonance (SPR) biosensor for real-time and ultrasensitive detection of prostate specific antigen (PSA) from clinical samples
Qureshi et al. Biosensors for cardiac biomarkers detection: A review
WO2007011936A3 (en) Lateral flow assay and device using magnetic particles
NO20076656L (no) Forbedrede immunoassay metoder
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
WO2010038974A3 (ko) 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트
DE60219207D1 (de) Diagnostisches testverfahren
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
DE602005015894D1 (de) Diagnostische testvorrichtung
DE602007003833D1 (de) Verbesserte vitamin-d-messung
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
Salama et al. Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens
Yamaguchi et al. Automated-immunosensor with centrifugal fluid valves for salivary cortisol measurement
WO2008067008A3 (en) A method for the quantitative evaluation of sex hormones in a serum sample
Afsarimanesh et al. Biosensors for the measurement of C-terminal telopeptide of type I collagen (CTX-I)
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
WO2008067007A3 (en) A method for quantitative measurement of thyroid homrones and related antibodies in a serum sample
CA2520438A1 (en) Latex reagent for adiponectin analysis and method of adiponectin analysis
Mikula et al. Electrochemical biosensor for the detection of glycated albumin
ATE421093T1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
WO2008066997A3 (en) A method for quantitative measurement of cardiac biochemical markers
ATE520985T1 (de) Verfahren zur bestimmung von antigen und antikörper gegen das antigen

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed